With the Taiwan Government granting approval for the use of QFT blood tests for TB today, is significant, considering that most of the population is BCG inoculated at birth.
My calculations are around 2.5 million tests per annum when fully implemented. Considering CST is selling currently around 2 million tests world wide this is a real fill up for the company in the long term.
By the way having attended the last AGM and listened intently to the CEO he went on to say "we do not make frivolous annoucements, when we make an annoucement it is of significant importance".
Cheers
CST Price at posting:
$3.49 Sentiment: Buy Disclosure: Held